Transaction in Own Shares

Summary by AI BETAClose X

GSK plc announced on October 17, 2025, that it purchased 310,000 of its ordinary shares, with a nominal value of 31¼ pence each, on October 16, 2025. The shares were bought through BNP Paribas SA, with prices ranging from a low of 1,621.50p to a high of 1,637.00p per share, and a volume-weighted average price of 1,629.84p. These shares will be held as treasury shares, forming part of the company's existing buyback program. Since September 30, 2025, GSK has purchased 4,229,500 ordinary shares. Following this transaction, GSK holds 251,694,344 ordinary shares in treasury and has 4,063,719,485 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to treasury shares is 6.19 percent.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings